Victory Capital Management
CLSD

Victory Capital Management’s Clearside Biomedical CLSD Stock Holding History

Victory Capital Management’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-840
Closed -$22K – 2664
2020
Q1 		$22K Buy
+840
New +$31.1K ﹤0.01% 3055
2019
Q4 		– Sell
-379
Closed -$4K – 2763
2019
Q3 		$4K Buy
+379
New +$5.43K ﹤0.01% 3497

Other funds holding CLSD

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Victory Capital Management's CLSD Position: Q2 2020 in Review

Victory Capital Management sold out of Clearside Biomedical (CLSD) in Q2 2020, closing a stake of 840 shares — an estimated $22K sold.

Victory Capital Management first reported a position in CLSD in Q3 2019 and held it in 2 quarters. The position peaked at $22K in Q1 2020. 45 funds tracked by Wall St. Rank hold CLSD as of Q2 2020.

  • Victory Capital Management reported no remaining Clearside Biomedical position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 840 Clearside Biomedical shares in Q2 2020, an estimated $22K.
  • Victory Capital Management first reported a position in Clearside Biomedical in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Clearside Biomedical position peaked at $22K in Q1 2020.
  • 45 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.